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Genetic testing has steadily become more popular in diagnostics and research use. Be-
cause the results of the genetic tests can have a large impact on the treatment and quality 
of life of an individual, the validity of the results and the quality of the laboratory work is im-
portant. 
 
The purpose of the thesis was to investigate possible factors affecting laboratory quality, 
and to create a small-scale literary review of suitable industry standards. In addition, a 
small laboratory experiment related to the development of a new test for Autosomal reces-
sive non-syndromic hearing impairment (ARNSHI) was performed in order to observe pos-
sible sources of error during molecular laboratory experiments. The observations were col-
lected into a separate document. The thesis was commissioned by Woble Helsinki Oy. 
 
DNA contamination is a large risk factor in polymerase chain reaction (PCR) analyses due 
to the sensitivity of the method. The biggest source of contamination is the DNA originating 
from already amplified samples. This has to be taken into account when planning the la-
boratory's layout, which has to be constructed in a way that allows the work to flow unidi-
rectionally from pre-PCR sections to post-PCR sections. The work areas should also be 
adequately decontaminated. 
 
Out of the three phases of a laboratory analysis, errors are most commonly made during 
the pre-analytic phase, and often include sample-patient mismatches and sampling errors. 
The second most common errors are the ones made during the post-analytic phase, and 
include errors associated with reporting. The analytic step is the most error-free, most 
likely due to the high degree of automatization present in analytic instruments. Errors can 
be prevented with personnel training and precise protocols. 
 
From the standards related to the field, ISO standards ISO 9001, ISO 17025 and ISO 
15189, GLP guidelines, OECD Guidelines for Quality Assurance in Molecular Genetic 
Testing, CLIA federal laws and CLSI guideline MMA-20 were examined. The ISO 17025 
and CLSI guideline were deemed most suitable and chosen as the basis of the new labor-
atory. 
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Geenitestit kasvattavat tasaisesti suosiotaan sairauksien diagnosoinnissa ja tutkimuskäy-
tössä. Koska geenitestien tuloksilla voi olla suuria vaikutuksia yksilön hoitoon ja elämän-
laatuun, on tulosten oikeellisuus ja laboratoriotyön laatu ensiarvoisen tärkeää.  
 
Opinnäytetyön tarkoituksena oli selvittää laboratorion laatuun vaikuttavia tekijöitä, sekä 
tehdä pienimuotoinen kirjallisuusselvitys olemassa olevista laboratorioon soveltuvista laa-
tustandardeista. Tämän lisäksi tehtiin pieni laboratoriokoe liittyen uuden autosomaalista re-
sessiivistä ei-syndromista kuulovammaisuutta (ARNSHI) detektoivan testin kehitykseen, 
jonka aikana tarkkailtiin laboratorion virhelähteitä. Huomioista tehtiin erillinen dokumentti. 
Opinnäytetyön toimeksiantaja oli Woble Helsinki Oy.  
 
DNA-kontaminaatio on suuri riskitekijä polymeraasiketjureaktioon (PCR) perustuvissa ana-
lyyseissa menetelmän herkkyyden vuoksi. Suurin kontaminaation lähde on toisista, jo mo-
nistetuista näytteistä tuleva DNA. Tämä on otettava laboratorion suunnittelusta asti huomi-
oon siten, että työ etenee tiloissa systemaattisesti ja yksisuuntaisesti pre-PCR-vaiheista 
post-PCR-vaiheisiin. Työpisteet tulee myös dekontaminoida riittävin tavoin. 
  
Kolmesta eri työn vaiheesta pre-analyysivaiheessa tehdyt virheet ovat kaikkein yleisimpiä 
ja liittyvät usein potilastietojen sekoittumiseen tai virheelliseen näytteenottoon. Toisiksi ylei-
simpiä ovat post-analyysivaiheessa tehdyt virheet, jotka liittyvät tietojen riittävään rapor-
tointiin. Vähiten virheitä tehdään varsinaisessa analyysivaiheessa, todennäköisesti analyy-
silaitteiden korkeasta automaatiotasosta johtuen. Virheitä voidaan ehkäistä henkilöstön 
koulutuksella ja tarkoilla protokollilla.  
 
Alaan liittyvistä laatustandardeista tarkasteltiin ISO-standardeja ISO 9001, ISO 17025 ja 
ISO 15189, GLP-ohjeistusta, OECD Guidelines for Quality Assurance in Molecular Genetic 
Testing -ohjeistuksia, USA:n CLIA-lakeja sekä CLSI:n MMA-20-ohjeistusta. Standardeista 
todettiin sopivimmiksi ISO 17025 ja CLSI-ohjeet, ja ne valittiin uuden laboratorion perus-
taksi.  
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ARNSHI Autosomal recessive non-syndromic hearing impairment 
CLIA Clinical Laboratory Improvement Amendments 
CLSI Clinical and Laboratory Standards Institute 
DNA deoxyribonucleic acid  
EU European Union 
FINAS Finnish Accreditation Service 
GJB2 Gene that encodes gap junction beta 2, also known as Connexin-26 
GJB6 Gene that encodes gap junction beta 6, also known as Connexin-30  
GLP Good laboratory practice 
ISO International Organization of Standardization, from Greek ‘isos’. 
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PCR Polymerase chain reaction 
qPCR Quantitative real time PCR 
RT-PCR Reverse transcriptase PCR 
SFS Suomen Standardisoimisliitto ry, from Finlands Standardiseringsförbund. 
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1 Introduction 
DNA tests are used to detect specific DNA sequences from the sample. In clinical context 
they are often referred as molecular diagnostics tests and can be used to detect, for 
example, genetic disorders [1]. The usage of molecular diagnostics tests has been stead-
ily rising, its global market size valued at over 4,8 billion USD in 2014 [2]. The direct-to-
consumer genetic testing market is a relatively small portion of it, its global value at 
around 70 million USD [3]. Since the results may have large impact on the possible treat-
ment and life quality of the patient, the validity of the results is exceptionally important. 
To ensure the validity of the results, the quality of the laboratory should be high. 
Since the factors affecting quality are so diverse, they have been narrowed to the two 
most prominent ones – DNA contamination, and errors occurring during, before and after 
the analysis. The sources of both are explored, as are the potential ways to prevent 
them. 
This thesis was done for Woble Helsinki Oy, a company that develops and performs 
direct-to-consumer DNA tests for detecting hereditary conditions. Currently the company 
operates in a very small scale laboratory, but is planning to begin working on a quality 
manual and expand its laboratory functions. The purpose of this thesis was to provide a 
literary review of factors affecting laboratory quality and possible suitable laboratory 
standards and guidelines so that the company could decide what would be best suited 
as the basis of their new quality manual and laboratory expansion. In addition to the 
literary review, a small laboratory experiment was performed to observe possible sources 
of error in a molecular testing laboratory. The knowledge gained from the literary review 
and the observations was also used to prepare a blueprint for the planned laboratory 
expansion. 
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2 DNA Contamination 
The strength of PCR techniques is their sensitivity, and the high number of amplicons – 
one PCR run can produce up to 1013 amplicon molecules. However, this makes PCR 
techniques vulnerable to contamination, as even a small amount of contaminating DNA 
in a sample or the equipment can affect the results of all subsequent tests. Contamina-
tion can cause false positives, which can have far-reaching effects in clinical and diag-
nostic applications. DNA contamination in this context refers to unwanted, non-sample 
DNA that has found its way into the sample, or any DNA that can be found on the equip-
ment. [4.] 
To ensure good operation, it is advisable for the laboratory to have a documented policy 
for detecting and controlling contamination, in addition to having policies and procedures 
for interpreting data that may have been affected by contamination, to ensure that the 
personnel take proper action when the situation arises. Contamination can be detected, 
for example, by running appropriate control reactions – a reagent blank can be used to 
detect reagent contamination, and if the laboratory has DNA-profiles of their personnel, 
contamination originating from them can be easily seen in negative control samples [5]. 
2.1 Possible sources 
DNA contamination can be caused both by primary transfer, where the DNA comes di-
rectly from the contaminant, and secondary transfer where a piece of equipment is con-
taminated and the DNA is subsequently transferred to another sample [6]. The three 
most common sources of contaminating DNA are DNA from the personnel, DNA from 
other samples in the lab and DNA fragments of the standard used to determine the size 
of amplified alleles. Contamination from bacteria or airborne contaminants such as pollen 
is possible, but generally causes no problems due to most molecular genetics tests being 
species-specific [5]. 
DNA can accumulate on the surfaces, tools and equipment within the laboratory, and 
pose a great risk of contaminating samples through secondary transfer [6]. Especially 
gloves have been found to contain significant amount of DNA [7], and should be changed 
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often. While certain guidelines recommend air-pressurized workrooms to prevent air-
borne contaminants [8, 9], air has been found to be an unlikely source of DNA contami-
nation [6, 10]. 
2.2 Preventive methods 
Due to DNA contamination being invisible to naked eyes and sometimes tricky to detect, 
not to mention hard to get rid of, preventing the contamination from occurring is critical. 
To reduce the risk of sample contamination by epithelial cells during DNA extraction and 
sample processing, personnel should wear protective clothing, including mouth masks. 
To prevent secondary transfer of contaminants, every section should have its own dedi-
cated equipment and reagents, and sterile and/or disposable consumables should be 
used. To prevent unnecessary movement between sections, all sections should also 
have their own storage cabinets, reagents, and fridges. Reagents should be stored in as 
small aliquots as possible, to minimize damage if a reagent container were to be con-
taminated. [9.] In the same vein, it is important to document which reagent containers 
were used for each analysis [5]. 
To prevent contamination by PCR products, there should be adequate separation be-
tween ‘clean’ pre-PCR functions (e.g. sample processing and master mix preparation) 
and ‘dirty’ post-PCR functions (e.g. PCR itself and any subsequent analysis). Exceptional 
care should be taken to separate post-PCR functions from the rest, due to the high con-
centrations of the potentially contaminating DNA. [8.] 
Simple way to accomplish this is physical separation, ideally by having a multiple room 
setup (Figure 1), or by having some other form of physical barrier between functions if a 
multi-room setup is not possible. Ideally, the laboratory should also be arranged in a way 
that allows for unidirectional workflow, to lessen the chances of PCR products ending up 
“upstream”. [8.] 
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Figure 1. Two-room option for a laboratory layout, modified from one presented by Raquel V. 
Viana and Carole L. Wallis [8]. 
In the clean area, the space should be further divided between sample processing and 
master mix preparation. A boxed PCR workstation or similar solution can be used during 
master mix preparation to minimize the risk of the currently processed sample contami-
nating the reagents, and to prevent foreign, non-sample DNA contaminating the master 
mix. [8.] 
The dirty area should ideally be separated into a PCR area and post-PCR area, which 
includes PCR product purification and any other possible post-amplification functions [8]. 
If the post-PCR analysis, such as sequencing, is performed elsewhere due to outsourc-
ing or other reasons, the outgoing sample packaging area should also be in the dirty 
area. Care should be taken to prevent the amplified DNA from contaminating the PCR 
equipment, for it is in contact with all the samples. In the case that the laboratory only 
uses qPCR methods, the dirty area can be a lot smaller since certain steps such as PCR 
product purification can be skipped. 
To ensure smooth operation, the laboratory should have documentation on how the la-
boratory contamination prevention plan is executed in practice and make sure this is 
understood by the personnel [9]. 
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2.3 Decontamination methods 
In addition to separation between functions, cleaning and decontaminating the work area 
between sample batches is crucial in preventing DNA carry-over contamination from 
other samples [8]. Therefore, a cleaning protocol and schedule should also be estab-
lished, documented and enforced [9]. There are two main ways to decontaminate sur-
faces and equipment: UV-light and chemicals. Heat can also be used to decontaminate 
equipment, but since the widespread use of disposable consumables renders it often 
unnecessary, it is not covered here. 
2.3.1 UV-light 
UV-light degrades DNA-molecules by causing the thymine molecules to react and form 
a dimer [11]. UV-light can be used efficiently to sterilize a small working space, such as 
that of a PCR workstation, where master mix preparation or similar sensitive steps are 
performed to proactively prevent contamination [8]. It can also be used to decontaminate 
a larger work surface, but doing so requires the entire workstation to be equipped with 
special illumination. Decontamination also takes a considerable amount of time, since 
95 % degradation may require even 1 hour of irradiation, depending on the intensity of 
the light and the distance of the light source from the surface. UV-light can also be used 
to decontaminate reagents and consumables; however, this has been found to decrease 
the performance of Taq–polymerases. Ideally, UV-light should be used together with 
chemical decontamination methods. [4.] 
2.3.2 Chemical 
There are several chemical decontamination methods, both generic substances and 
specific commercial products. Since the active ingredients in commercial solutions are 
rarely disclosed, only generic substances are discussed here. In general, chemical de-
contamination methods are slightly more efficient than UV-light for routine decontamina-
tion of working surfaces and equipment [4]. They can also be more easily applied to 
uneven surfaces, such as door handles. 
One of the most common chemical decontaminating methods used in laboratories is 
ethanol, which is most commonly used as a 70% solution to disinfect surfaces by wiping. 
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Ethanol based commercial disinfectants are myriad, and they are used by even the most 
high-end laboratories, such as Finland’s NBI forensic laboratories [12]. Despite ethanol 
being very effective at disinfecting surfaces from microbes and other such contaminants, 
it does not degrade DNA – it merely causes it to precipitate [13]. Hence, while ethanol is 
an excellent tool to upkeep good general hygiene, it should be used in tandem with other 
decontamination methods. 
Sodium hypochlorite, also known as bleach, is commonly used as 10 % chlorine bleach 
solution to disinfect surfaces by wiping. It is very effective, achieving up to 95,4 % DNA 
degradation [4]. On the other hand, the self-life of bleach is only 6 months, and 10 % 
solutions must be prepared every day for they lose their effectiveness after 24 hours [14]. 
Bleach solutions can also corrode stainless steel instruments and can produce chlorine 
gas if in contact with acids. 
Hydrogen peroxide is also a very efficient disinfectant, demonstrating 97 % effectiveness 
when used as a 3 % water solution [15]. Unlike bleach, hydrogen peroxide is non-corro-
sive and does not release toxic fumes. 
Copper complex solutions, such as copper-bis-(phenanthroline)-sulfate/H202 solution, 
can also be used very effectively to disinfect surfaces by wiping. Copper complex solu-
tions are roughly as effective as bleach, achieving 95,5 % DNA degradation [4]. How-
ever, they are not widely commercially available, possibly due to the carcinogenic prop-
erties of copper. 
3 Sources of errors in a molecular genetics laboratory 
In addition to DNA contamination, there are a multitude of other errors that can affect the 
quality of the laboratory results. Unfortunately, no clear line can be drawn to where la-
boratory errors begin and pre-laboratory errors end, since the clerical errors made during 
the sampling or ordering of the test also affect the practical outcome of the analysis. 
However, distinction can be made between errors made exclusively, physically inside 
the laboratory, and laboratory errors caused by organizational problems outside the la-
boratory, for example, sample-patient mismatch during sampling. [16.]  
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3.1 Different phases of process 
The analytical process can be split into three phases: pre-analytic, analytic and post-
analytic phase. Most errors occur in the pre-analytic phase and the least in the analytical 
phase [17]. While the precise numbers vary; in general, the distribution between the 
phases is very similar in many testing areas, including molecular genetic testing [18]. 
3.1.1 Pre-analytic phase 
The pre-analytical phase describes all activities from test ordering to the time the sample 
arrives in the laboratory [19], including test selection done by the customer or physician, 
patient identification and preparation, various specimen collection procedures and the 
transport, and possibly including the transferring of patient information to the laboratory’s 
computer systems [17, 19]. 
The pre-analytical phase is very vulnerable, with up to 61,9 % of all errors being made 
during this phase [17]. The types of errors made in this phase are diverse, but most of 
them are related to incorrect sampling. Other error sources outside the laboratory are 
inappropriate test requests and order entry errors, misidentification of the patient before 
and/or after sample is taken, and improper labeling of sample containers. Errors made 
within the laboratory include errors related to sample logistics and labeling. [20.] 
3.1.2 Analytic phase 
The analytic phase refers to the actual analysis performed by the laboratory personnel, 
including the selection of test methods, performance of test procedures, and monitoring 
and verification of the test results [18]. During the last 40 years the rate of errors made 
during this phase has decreased dramatically, with only 15 % of errors made during the 
phase. This development is most likely due to the widespread automatization of analyz-
ers that reduce the chance of human error [17, 19]. Integrated computer technology has 
also greatly aided accurate and consistent specimen identification and handling, and test 
result reporting [19]. However, equipment malfunction, sample mix-ups, interference and 
undetected failures in quality control persist as sources of error during the analytical 
phase [20].  
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3.1.3 Post-analytic phase 
The post-analytic phase consists of reporting the test results to either the clinician or the 
customer who ordered the test, and archiving records, reports and tested specimens. 
The major sources of error are patient-result mismatch, and the receiver – either a cus-
tomer or a physician - misinterpreting the results. Misinterpretation may in some cases 
be caused by insufficiently informative test reports, as physicians of many medical spe-
cialties consider reports that include information beyond that specified by the national 
requirements to be more helpful, than those that contain the bare minimum. [18.] 
3.2 Error prevention 
In the general sense, the laboratory quality management system should have policies 
and procedures for detecting, monitoring and reporting errors. Any errors found should 
be reviewed and the cause investigated. Any actions taken to solve the problem should 
be documented, and the effectiveness of the actions should be monitored. [21.] 
In order to reduce the prevalence of technical errors during the analytical phase, the 
training and experience of the personnel is important [16]. Therefore, the laboratory 
should also have policies and procedures to ensure that the staff has the training and 
qualifications needed to perform their assigned tasks. Since laboratory methods always 
evolve, sometimes rapidly, there should also be procedures to ensure the staff receives 
education and training during their employment. Adequate training is also important in 
the pre-analytical phase if automatization, such as electronic forms or barcode scanners, 
are used to reduce human error during the phase.  
To reduce the errors caused by instrument malfunction, the staff should be adequately 
trained to operate them, and the laboratory should have policies and procedures to en-
sure the equipment is properly maintained and calibrated [21]. 
4 Standards and guidelines considered 
In order to verify that their laboratory meets the basic benchmarks of quality discussed 
in earlier chapters, molecular genetics laboratories can use and seek accreditation to 
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several quality standards. Operating in accordance to an internationally accepted stand-
ard tells potential customers that the laboratory meets the requirements needed for high 
quality molecular genetics testing. 
4.1 ISO standards 
ISO/IEC standards are issued by the International Organization of Standardization (ISO), 
which is formed by an international network of accreditation bodies [22]. In Finland, ISO 
standards are issued through Suomen Standardisoimisliitto SFS ry (SFS) and laborato-
ries can seek ISO accreditation through Finnish Accreditation Service (FINAS) [23, 24]. 
4.1.1 ISO 9001 
ISO 9001 is a general quality management standard that can be applied to any organi-
zation regardless of their size or scope. The standard focuses on quality management 
system implementation, management responsibilities, resource management and how 
the principles of continuous improvement are to be implemented. The standard does not 
contain any technical requirements. [25.]  
ISO 9001 encourages businesses to adopt a “process approach” to how the quality man-
agement system is implemented, meaning that the whole system is divided into small 
sub-processes, “process” here being anything that transforms input into output. The 
standard also requires businesses to continually improve their management systems 
through user input and internal audits, or at least construct their management in a way 
that allows this. 
While many of the management principles of ISO 9001 can and should be applied to 
laboratory work, the standard does not include technical requirements and thus it cannot 
be used to prove the laboratory’s technical competence. In addition, while the standard 
mentions that the “product” can also mean a service, it still seems to have been written 
with the manufacturing industry in mind.  
The implementation of ISO 9001 also requires a lot of administrative work that small 
companies may not have the resources for. The standard’s requirements for every pro-
cedure, decision and policy to be extensively documented, while extremely good and 
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useful, require a very robust document handling system that small companies may lack. 
The standard may also be challenging to implement without any external guidance, due 
to the very generic nature of the requirements. In summation, while the standard is not 
unsuitable for laboratories, the effort may be better spent in implementing a standard 
that is better tailored for the laboratory industry.  
4.1.2 ISO 17025 
ISO 17025 is a generic laboratory quality standard that specifies the general require-
ments for the competence to carry out tests and/or calibrations. The standard is applica-
ble to all laboratories regardless of their size or scope of activities, be it commercial, 
industrial or federal. ISO 17025 also includes the requirements of ISO 9001 that are 
relevant to the field. [21.] 
The standard is comprised of management requirements and technical requirements. 
The management requirements are very similar to those found in ISO 9001, encompass-
ing organizational structure, management system and document handling. Most im-
portantly, the standard requires the laboratory to have a quality manual and details what 
it must contain. The ISO 17025, however, does not mention the “process approach” en-
couraged in ISO 9001 [25], possibly because the scope of this standard is already so 
much narrower that dividing the laboratory to sub-processes is unnecessary. 
In addition to the management requirements, ISO 17025 also contains technical require-
ments not found in ISO 9001. Due to the need for the standard to be applicable to any 
laboratory regardless of field, the technical requirements are very general in nature and 
consist mainly of requirements for personnel qualifications, data control, and test report 
contents and procedures. 
The standard is internationally accepted, and an accreditation to ISO 17025 is a widely 
accepted quality indicator for laboratories. However, the standard does not contain any 
specific requirements for molecular genetics testing laboratories, and designing a labor-
atory without external guidance may be difficult due to the lack of specialized require-
ments for the field. Similarly to the case with ISO 9001, a small company may not have 
the resources for the administrative work and documentation that the successful imple-
mentation of ISO 17025 requires, as useful as they are. Nevertheless, if these resource 
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limitations can be overcome ISO 17025 is a solid, if a slightly barebones option, for mo-
lecular genetics testing laboratories. 
4.1.3 ISO 15189 
ISO 15189 is a standard that contains managerial and technical requirements for medical 
laboratories. The standard defines medical laboratories as laboratories that run exami-
nations of materials derived from the human body for the purposes of health assessment 
or diagnosis, treatment or prevention of disease. [26.]  
The standard is comprised of management requirements and technical requirements 
and includes relevant requirements from ISO 17025. The management and technical 
requirements are very similar to those in ISO 17025, with added emphasis on patient 
care and well-being. In addition, technical requirements have been categorized into pre-
examination, examination and post-examination processes, as is common with clinical 
standards. 
Even though a laboratory developing and performing molecular genetics tests could fall 
under the definition of a medical laboratory, ISO 15189 is intended to be used in a med-
ical laboratory that operates within a hospital or in close co-operation with the health care 
industry As a direct result of this, the standard assumes that laboratory service requests 
are made by a clinician, which can be a cause of confusion if the standard is implemented 
in a direct-to-consumer genetics laboratory. Like ISO 17025, ISO 15189 lacks any re-
quirements specific to molecular testing industry, and the administrative work and docu-
mentation required may be beyond a small company’s resources. In summation, while 
the standard is by no means unsuitable, other standards such as ISO 17025 should be 
considered instead, unless the company is certain that they are a medical laboratory. 
4.2 OECD guidelines 
Organization for Economic Cooperation and Development (OECD) is an organization 
that designs and publishes policies and standards for many fields. The policies are made 
with the aim of delivering positive effects on the economic and social well-being of peo-
ple. OECD originated as a European organization, but in the present day has 34 member 
countries worldwide, including Finland. [27.] 
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4.2.1 OECD Guidelines for Q. Assurance in Molecular Genetic Testing 
In 2002, OECD carried out a survey to measure the availability of molecular genetic 
testing and to document existing quality assurance practices. The results showed that 
while all participating OECD countries had mechanisms to assure the quality of molecu-
lar genetic testing procedures, these regulatory procedures had not been adopted in 
laboratories consistently. Since one of the identified causes was that the regulations had 
not been designed for molecular genetic testing specifically, OECD set out to create and 
publish a guideline titled OECD Guidelines for Quality Assurance in Molecular Genetic 
Testing in 2007. [28.] 
The OECD guidelines are designed to provide principles and best practices for quality 
assurance in molecular genetic testing for clinical purposes. The principles are directed 
primarily at government and regulatory bodies, whereas the best practices are aimed for 
laboratories and other establishments involved in the provision of molecular genetic test-
ing. Testing carried out only for research purposes is not addressed. The guidelines are 
also partially relevant and applicable to aspects of biochemical genetic testing. 
The principles and best practices defined in the guideline cover general information, 
quality assurance systems, proficiency testing, quality of test reporting, and educational 
standards for laboratory personnel. Since the principles are aimed at government bodies, 
only best practices are covered here. 
The best practices related to quality assurance systems include requirements for the 
terminology used, accreditation, documentation and periodical review of analytical valid-
ity. For proficiency testing, there are requirements for how it should be arranged and 
structured. The best practices related to quality of test reporting include requirements for 
the minimum information that should be in a report, and that the reports should take in 
account that the recipient may not be a specialist health care professional. The educa-
tional requirements include that the laboratory personnel should have relevant qualifica-
tions and receive continuing education. 
The guideline is narrower than the ISO standards are, but they are similar in content. 
The statements in the guideline are very brief and general in nature, making it very hard 
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to utilize as the main base for building a laboratory quality system. It is, however, distrib-
uted free of charge and thus can be easily used to supplement other standards, such as 
the field-nonspecific ISO 17025. 
4.2.2 GLP guidelines 
Good laboratory practice (GLP) is a standard by which laboratory studies are designed, 
implemented and reported and has been widely adopted due to the GLP principles pub-
lished by OECD in 1998. OECD principles on GLP are meant to be applied to any non-
clinical safety testing of synthetic or organic chemicals in pharmaceutical, pesticide or 
cosmetic products, food additives and industrial chemicals [29]. GLP is also integrated 
into the EU-directives. Within EU, unless specifically exempted by national legislation, 
GLP applies to all health and safety studies required by regulations that are performed 
for the purpose of registering or licensing products mentioned above. [30.] In Finland, 
GLP monitoring is conducted by Fimea [31].  
The requirements defined in GLP principles include, but are not limited to, requirements 
for the test facility organization and personnel, the laboratory’s quality assurance pro-
gramme, facilities, materials and equipment, test systems and reference items, standard 
operating procedures, and how the test data is reported to authorities [29]. 
While accordance to GLP is required only of GLP-certified research laboratories, most 
GLP principles can be applied to any industry in which laboratory work is performed. 
That said, GLP does not contain any specific requirements for molecular laboratories. It 
is available free of charge, however, and thus can be used as a complimentary piece 
while building a quality management system. 
4.3 MIQE guidelines 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments 
(MIQE) were published in 2009 and authored by Stephen A. Bustin et al. The guidelines 
are the third most cited paper published in Clinical Chemistry [32], with over 4000 cita-
tions according to Google Scholar [33]. 
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The guideline aims to unify qPCR data reporting to the point that all papers adhering to 
the guidelines provide the reader enough information to judge whether the data is sound, 
or to even repeat the test. The guidelines are presented as a checklist for authors to use 
when submitting the initial manuscript to the publisher. The guideline also defines certain 
vocabulary, such as whether RT-PCR refers to real-time or reverse-transcript PCR, to 
make sure that scientific publications can be as unambiguous as possible. [34.] 
The checklist items listed in the guide and their contents are given below: 
 Experimental design, namely the sizes of experimental and control groups 
 Sample description, processing and storage conditions 
 Nucleic acid extraction information, such as the method and kit used 
 Reverse transcription information, such as complete reaction conditions 
and volume 
 qPCR target information, such as gene accession number and amplicon 
length 
 Information on qPCR oligonucleotides, such as primer sequences 
 qPCR protocol information, such as complete reaction conditions and vol-
ume 
 qPCR validation information, such as specificity, calibration curves and 
PCR efficiency 
 Data analysis information, such as the analysis program used and justifi-
cation for number and reference genes. 
The checklist items are divided to either essential information that is to be submitted with 
the manuscript, or desirable information that should be submitted if available. 
MIQE Guidelines are very useful, for they contain very specific guidelines for writing sci-
entific papers. Due to its format it does not, however, go into great detail about the spe-
cifics of each checklist item, which can make certain items hard to understand. For this 
reason, it is advisable to couple the guidelines with a guide of some sort. The guideline 
is free of charge and widely accepted; thus, there is not much reason to not use it. 
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4.4 CLIA federal regulations 
Clinical Laboratory Improvement Amendments (CLIA) are federal standards applicable 
to all facilities in U.S that test human specimens for health assessment or to diagnose, 
prevent or treat disease [35].  
CLIA regulations include requirements for laboratory's management system and tech-
nical requirements for its operations. The requirements vary significantly according to the 
category the laboratory belongs to; the category, in turn, is assigned according to the 
category of the tests performed. [36.] 
CLIA categorizes tests by simplicity. A test can be considered a waived test if it fulfills 
the following requirements:  
 It employs simple laboratory examinations and procedures that have been 
cleared by FDA for home use. 
 It uses methodologies that are accurate and simple enough to make the 
likelihood of error minimal, OR… 
 It employs methods that pose no reasonable risk of harm to the patient if 
the test is performed incorrectly. 
The categories for tests of moderate complexity and high complexity are determined by 
a scoring system that measures the following:  
 knowledge required to perform tests 
  training and experience required to perform tests 
  complexity of reagents and materials (i.e. do they need to be prepared) 
  characteristics of operational steps 
  complexity and importance of correct calibration to the results 
  quality control and proficiency testing materials 
  complexity of equipment troubleshooting and maintenance 
  amount of interpretation and judgement the tests need 
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 Each attribute is given a score from 1 to 3. If the test system's score is above 12, it will 
be categorized as high complexity - otherwise, the test is categorized as moderate com-
plexity [36]. At a glance, most molecular genetic tests tend to fall under high complexity. 
CLIA regulations are extensive and include useful and specific instructions for the facili-
ties of a molecular diagnostics laboratory. However, successful implementation of CLIA 
regulations requires the laboratory to asses all its test systems, which may be overly 
arduous for a small-scale laboratory. In addition, CLIA compliance is recognized only in 
the U.S. Therefore, for a non-U.S based laboratory, other standards and guidelines 
should be considered. 
4.5 CLSI guideline MM20-A 
Clinical and Laboratory Standards Institute (CLSI) is a non-profit organization that pub-
lishes voluntary consensus standards and guidelines, reports and companion products 
such as Quick Guides. The laboratory testing standards are developed on the basis of 
input from and consensus among industry, government, and health care professionals 
[37]. CLSI participates in the development of international ISO standards as the ISO TC 
212, which is responsible for clinical laboratory testing and in vitro diagnostics test sys-
tems [38].  
For establishing a quality management system for a molecular genetics testing labora-
tory, CLSI offers guideline MM20-A. MM20-A is intended for use by medical laboratories 
that perform molecular genetic testing for inherited or acquired conditions. Even though 
many quality system principles described in MM20-A are applicable to most medical la-
boratories, it is not intended to address non-clinical molecular testing or direct-to-con-
sumer laboratory services. [39.] 
MM20-A contains instructions for organizational structure, personnel qualifications and 
document control. For technical requirements, MM20-A separates functions to pre-ana-
lytical, analytical and post-analytical activities similar to ISO 15189. MM20-A also offers 
a list of related CLSI reference materials and examples of quality manuals and several 
forms. 
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MM20-A is an in-depth guideline for molecular laboratories. It is, however, a voluntary 
guideline and laboratories cannot seek accreditation to it. Due to the close ties CLSI has 
to governments around the world and the ISO, the guideline is most likely in line with 
ISO 17025 and ISO 15189 standards, making them viable accreditation goals for a la-
boratory that follows MM20-A. 
5 Additional documents 
In addition to the literary review, two documents were prepared as a part of this thesis. 
The first one is a list detailing possible sources of error in a molecular genetics laboratory 
and ways to avoid them, based on observations made during a laboratory experiment. 
The list is to be used as the starting point of the company’s quality manual. The second 
document is a blueprint for the planned laboratory expansion that utilizes knowledge 
gained from the literary review. 
5.1 Laboratory experiment 
A small laboratory experiment was conducted as a part of the thesis. The main focus of 
the experiment from this thesis’s perspective was to observe possible sources of error 
and how the laboratory should be arranged to ensure a smooth workflow. These obser-
vations were used together with the standards and other sources to create a document 
called Suggestions for laboratory operations (Appendix 1), which will be used as the 
starting point for the company’s quality manual. The document groups the suggestions 
by analytical phases, as pictured with example observations in Table 1. 
Table 1. Examples of observations recorded in Suggestions for laboratory operations. 
Phase Notes 
General There should be an adequate supply of laboratory consum-
ables. 
Wearable protection should be adequately sized. 
Pre-PCR phase All sample tubes should be clearly marked. 
To prevent contamination from PCR products, there should 
be no in-flow from post-PCR area. 
PCR and post-PCR The post-PCR area should have its own consumables 
The post-PCR area should have its own protective equip-
ment 
The protective equipment should be marked to prevent ac-
cidental usage in pre-PCR areas 
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The experiment itself was part of the development process of a new molecular diagnos-
tics test for autosomal recessive non-syndromic hearing impairment (ARNSHI), and it 
was performed in the company’s pre-expansion laboratory, which is described in chapter 
5.2. 
Hearing impairment is a highly heterogenous sensory disorder, caused by genetical fac-
tors in 60 % of the cases [40]. In many populations, up to 50 % of all cases of ARNSHI 
are caused by mutations in the GJB2 gene, which encodes connexin-26. Connexin-26, 
among other connexins, has been shown to participate in the complex potassium ion 
cycle in the mammalian cochlea [40]. Molecular testing for GJB2 mutations is the stand-
ard of care for diagnosis of non-syndromic hearing impairment of unknown cause. How-
ever, a deletion in the neighboring connexin-30 gene, GJB6, was found to be present in 
up to 50 % of patients affected by ARNSHI [40]. Total of 26 mutations have been found 
to be associated with connexin-26 [41]. 
The goal of the experiment was to test several primer pairs for use in the development 
of a new diagnostics test for ARNSHI. The primer pairs were selected based on the 
findings of Ram Shankar Mani et al. [41] and a study by F J del Castillo et al. [40] 
In the experiment, a total of 5 primer pairs were tested (appendix 2) using a known se-
quence, out of which Cx26-2F was additionally used to test 6 samples from patients with 
no ARNSHI to check against the primers giving false positives. Each was made with a 
duplicate. A standard 32-cycle PCR procedure was performed with the annealing tem-
perature of 56 °C for 15 seconds and the extension temperature of 72 °C for 40 seconds.  
The PCR products were purified using an Illustra Exoprostar kit, which utilizes alkaline 
phosphatase and exonuclease 1. After purification, the duplicates were used to verify 
the success of the amplification via gel electrophoresis, which was performed using Invi-
trogen E-gel precast agarose gels and E-gel loading buffer. The remaining samples were 
sent to a sequencing laboratory for further analysis and prepared according to the other 
laboratory’s instructions.  
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5.2 Laboratory Blueprint 
Prior to the completion of this thesis, the company operated in a very small scale labor-
atory. Both the pre-PCR and post-PCR reactions were performed in a single room, on 
the same workbench, which also housed office supplies. However, the planned expan-
sion was intended to remedy this and improve the quality of the company’s laboratory 
work.  
As established in chapter 2.2, the positioning and separation of work areas is crucial in 
preventing cross-contamination between pre- and post PCR areas in a molecular genet-
ics laboratory. Therefore, to establish good laboratory quality, the laboratory layout has 
to be carefully considered during construction. For this reason, a blueprint for the labor-
atory expansion was prepared in addition to the document mentioned in chapter 5.1. 
Ideally, a molecular genetics laboratory would be split into two or three separate rooms 
– a pre-PCR area, a separate PCR area, and a post-PCR area. However, since the 
blueprint is intended to be used as the basis for the company’s new laboratory, the real 
life limitations of the space have been taken into account. Due to size and budget con-
straints, the laboratory is planned to be in one room, with different functions being sepa-
rated by wooden panels (Figure 2). As discussed earlier in chapter 2.1, air is an unlikely 
source of contamination; therefore, air pressure and air flow have not been taken into 
account. 
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Figure 2. The hypothetical laboratory blueprint, with the different areas color-coded as follows: 
mailroom = green, pre-PCR = blue, post-PCR = red. The horizontal panel separates the la-
boratory area from the office space. 
The company receives their samples through mail and thus needs a dedicated mail pro-
cessing area. To avoid patient-sample mismatch, patient information is entered into the 
electronic system immediately and barcode stickers are used to identify sample tubes 
throughout the process. Since the mail processing area has the most potential to become 
cluttered due to envelopes and other packaging materials, and the incoming mail poten-
tially bringing in foreign contaminants, the area is separated from the more sensitive pre-
PCR functions. 
The mail processing area (Figure 3) has a workbench, surrounded by a cleaning supplies 
cabinet and waste bin. Laboratory consumables, such as gloves, are stored on an over-
head shelf for easy access. The sample envelopes are opened, the patient information 
is inputted into the electronic system, samples stickered with bar-code stickers and 
moved forward. The work area is thoroughly cleaned after a sample batch. Since no DNA 
extraction is performed during this step, protective clothing other than gloves is optional. 
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Figure 3. The mail processing area: (1) workbench, (2) overhead shelf for consumables, (3) 
waste bin, (4) cleaning supplies cabinet. 
The sample preparation, DNA extraction and master mix preparation are all combined 
into one pre-PCR area. To prevent contamination from post-PCR areas, the area has its 
own dedicated reagents, storage, cold storage, tube racks, gloves and other laboratory 
consumables. Protective clothing such as coats and face masks are also readily availa-
ble and should be used to prevent contamination. 
Like the other areas, the pre-PCR area (figure 4) has a workbench, surrounded by a 
cleaning supplies cabinet, an overhead shelf for consumables, and a waste bin. In addi-
tion to the items found in the previous area, the pre-PCR area also has a reagent storage 
cabinet and a fridge/freezer for sample storage and temperature-sensitive reagent stor-
age. A coat rack is located near the entrance, as far away from the workbench as possi-
ble, so that protective equipment can be taken off and put on without the danger of kick-
ing up contaminating dust and/or knocking anything down. The work area is thoroughly 
cleaned between sample batches. 
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Figure 4. The pre-PCR area: (1) workbench, (2) overhead shelf for consumables, (3) waste bin, 
(4) cleaning supplies cabinet, (5) storage, (6) cold storage, (7) coat rack. 
Ideally, the PCR functions should have their own room, but due to limited space, both 
the PCR and post-PCR functions are placed in the third area. To prevent the PCR equip-
ment from becoming contaminated, the machine has a dedicated, marked space where 
post-PCR functions are forbidden. Since the company sends certain samples by mail to 
be further analyzed, the outgoing mail packaging area is also located in the third area. 
To prevent potentially contaminated equipment or supplies from moving to more sensi-
tive areas, the area has its own reagents, storage and laboratory consumables. The area 
also has its own protective equipment, clearly marked to prevent mix-up or other acci-
dental usage in other areas.  
The post-PCR area (Figure 5) has a workbench surrounded by an overhead shelf for 
consumables, a cleaning supply cabinet and a waste bin. The post-PCR area also has 
a reagent storage and a fridge/freezer. A coat rack is located near the entrance, but on 
the opposite side of the pre-PCR area, to minimize the chances of contamination through 
air or any mix-up between pre- and post-PCR coats. The work area is thoroughly cleaned 
between sample batches, and the PCR products are either analyzed and disposed, or 
packaged and sent forward.  
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Figure 5. The PCR and post-PCR area: (1) workbench, (2) overhead shelf for consumables, (3) 
waste bin, (4) cleaning supplies cabinet, (5) storage, (6) fridge, (7) coat rack, (8) outgoing 
mail packaging area, (9) marked PCR area. 
The workflow and general layout are designed to be unidirectional, to reduce the risk of 
contamination from post-PCR products (Figure 6). In addition to PCR cleanliness, care 
was taken to reduce human error by making the laboratory layout as ergonomic and easy 
to use as possible by making sure waste bins, reagent storage and consumable storage 
are all close to the working areas. 
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Figure 6. The laboratory layout, with the workflow illustrated. The sample enters from the right, 
travels through the areas, and exits from the left, usually either in a waste bin or in a mail 
package. Personnel are only allowed to walk from right to left. 
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6 Conclusions 
The purpose of the thesis was to investigate the factors affecting the quality of molecular 
laboratories. The factors affecting laboratory quality are diverse, but the most important 
factor in molecular testing is its vulnerability to contamination. Therefore, contamination 
prevention should be taken into account during every step of setting up the laboratory, 
starting from the facility design and continuing to the design of analysis protocols and 
day-to-day cleaning protocols.  
The second factor affecting quality is the possible clerical and analytical errors performed 
before, during, and after the analysis. Since many molecular tests are used to detect 
mutations for research or diagnostics purposes, errors can have surprisingly far-fetching 
consequences. Most of the errors are performed in the pre- and post-analytical steps, 
and for this reason these steps should be the main focus when designing error-prevent-
ing protocols, as opposed to the analytical step. 
The other purpose of this thesis was to collect and review industry standards and guide-
lines that could be used for a molecular genetics laboratory. The standards chosen were 
three ISO standards, ISO 9001, ISO 17025 and ISO 15189, GLP and Quality Assurance 
Guidelines for Molecular Genetic Testing by OECD, MIQE guidelines, CLIA federal reg-
ulations and the CLSI guideline MMA-20.  
Out of the three ISO standards, the general laboratory quality standard ISO 17025 was 
found to be the most applicable. ISO 9001 is a general quality standard and, while not 
exactly unsuitable, does not provide tools to improve a laboratory’s technical compe-
tence. ISO 15189 on the other hand is designed for medical laboratories and thus in-
cludes many clauses that are not applicable for this particular business setup. 
GLP guidelines by OECD were also considered, but were dismissed since they are in-
tended to be used in research laboratories. Quality Assurance Guidelines for Molecular 
Genetic Testing is also published by OECD, and while intended for the exact purpose 
the company seeks a standard for, is too brief to be used as the basis of a quality man-
agement system on its own. 
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MIQE guidelines are different from the other standards, since they are intended solely 
for improving the quality of published qPCR data. They do succeed in this very well how-
ever, and are widely used. 
CLIA federal regulations differ from international standards due to their complexity based 
ranking system and ranking-based requirements. Unlike the very general ISO standards, 
the regulations offer more specific and in-depth requirements for laboratories. There are 
no glaring faults in the regulations; however, the greatest issue in designing a quality 
management system based on them is the fact that they are only recognized in the U.S. 
The CLSI guideline MMA-20, on the other hand, also contains specific instructions for 
molecular laboratories, and unlike the OECD guidelines on the same subject, is very 
extensive. 
On the basis of the findings during this thesis, the company concluded that it would begin 
by implementing OECD and CLSI standards, with accreditation to ISO 17025 planned at 
a later date. Due to the CLSI accounting for other industry standards and the co-opera-
tion with ISO standards, there should not be much modifying needed to accommodate 
ISO 17025 later. At the time of the writing, the new laboratory expansion has also been 
built roughly in accordance with the blueprint prepared during this thesis project. 
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Appendix 1: Suggestions for laboratory operation 
A list of things to consider in a molecular diagnostics laboratory 
General instructions: 
 There should be an adequate supply of laboratory consumables 
o E.g. disposable gloves, pipette tips and plastic tubes 
 Wearable protection should be adequately sized 
 All relevant data is to be written into the laboratory notebook immediately 
o Notes should include: date, author, sample/patient id, mention of 
procedure used, possible calculations, the kit and/or own reagents 
used 
 The laboratory notebook should always be available at the workbench 
o Possible electronic system should be such that it allows making 
notes easily while working 
 If laboratory-made reagents are used, their recipe should be documented 
and easily available at the workbench 
 Reagent solutions should be well-labeled 
o Labels should include: date, author, dilution ratio, reagent stock 
lot number, kit lot number if the reagent is from a kit, and buffer 
used if relevant 
 External disturbance should be minimized 
o The workroom should not be in a particularly noisy location 
o The workroom should be free of unnecessary traffic 
 Storage solutions should be arranged in an easily accessible way 
 Waste disposal bins should be arranged in an easily accessible way   
o Every function should have its own waste bin 
o If the waste bin cannot be reasonably placed near the workbench, 
there should be a small bin on the workbench for small consuma-
bles 
 Protocols, procedures, and other such information should be documented 
and available at the laboratory  
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  Laboratory housekeeping responsibilities and duties should be docu-
mented and available at the laboratory 
 
Sample reception and preparation 
 Sample tubes should be clearly marked 
o The markings should include at least the sample name or patient 
id 
 The workbench should have enough space for both laboratory work and 
note making 
o The workbench should be clear of unnecessary items 
o The laboratory notebook/laptop should have its own reserved  
space 
 The workbench should have a workflow, e.g. from least processed to 
most processed 
 To prevent contamination from PCR products, there should be no in-flow 
from post-PCR area 
o Sample preparation area has its own consumables 
o Sample preparation area should have its own reagent storage 
 Adequate measures should be taken to prevent contamination from the 
employee(s), e.g. coats and gloves should be worn 
o Since the company processes samples taken from mouth epithe-
lial cells, face masks should be considered 
 
Pre-PCR 
 To make sure the correct analysis is done, samples should have relevant 
information added to them upon registration to the system. 
 To make sure the correct reagents needed are chosen, test protocols 
should be documented and available at the workbench 
 The test tubes should be clearly marked, either with a sticker or otherwise 
o If the tube is too small for a full description (e.g. PCR-tubes) and 
a code is used (e.g. 1,2,3…) the code is documented in the labor-
atory notebook. 
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 The workbench should have enough space for both laboratory work and 
note making 
o The workbench should be clear of unnecessary items 
o The laboratory notebook/laptop should have its own reserved  
space 
 The workbench should have a workflow, e.g. from least processed to 
most processed 
 To prevent contamination from PCR products, there shall be no in-flow 
from post-PCR area 
o The pre-PCR area has its own consumables, and in the event of 
them running out, they should not be restocked from the post-PCR 
area 
o The pre-PCR area has its own lab coats 
o The border between pre- and post-PCR areas should be clearly 
marked, so the personnel are in the clear where they should 
change their lab coats etc. 
 Adequate measures should be taken to prevent contaminating the rea-
gents with unprocessed DNA-products 
o Reagent supplies should be verified before the analysis begins, to 
prevent reagents from running out in the middle of the analysis 
o Reagents should be stored as small aliquots 
o Interrupting the current analysis to prepare more reagents in-
creases the risk of human error considerably, and should be 
avoided 
 Pre-PCR area has its own reagent storage and fridge 
o The fridge is to be kept free of any unnecessary items (e.g. food) 
 The workbench is cleaned with an adequate cleaning solution (e.g. H2O2) 
between sample batches  
 The workbench and surrounding area should be scheduled to be thor-
oughly decontaminated periodically 
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PCR and Post-PCR 
 PCR procedures should be documented and available at the workbench 
 The test tubes should be clearly marked, either with a sticker or otherwise 
o If the tube is too small for a full description (e.g. PCR-tubes) and 
a code is used (e.g. 1,2,3…) the code is documented in the labor-
atory notebook. 
 The workbench should have enough space for both laboratory work and 
note making 
o The workbench should be clear of unnecessary items 
o The laboratory notebook/laptop should have its own reserved  
space 
 The workbench should have a workflow, e.g. from least processed to 
most processed 
 The post-PCR area should have its own consumables 
 The post-PCR area should have its own protective equipment 
o The protective equipment should be marked to prevent accidental 
usage in pre-PCR areas 
 To prevent the contamination of PCR equipment, it should be clearly sep-
arated from the post-PCR work area 
 If gel electrophoresis is performed, the well-sample pairs should be writ-
ten down into the laboratory notebook 
o if traditional (i.e. non-encased) gels are used, the wells should be 
filled asymmetrically to prevent confusion if the gel is flipped 
 If any procedure that requires temperature sensitive reagents is per-
formed, a cold block or similar solution should be prepared before the 
work begins 
 There should be no flow of samples from the post-PCR area 
o Samples are disposed, if they’re not sent out for further analysis 
o There should be a packaging area for outgoing samples 
 Outgoing samples are carefully documented to the laboratory notebook 
o The notes should include at least: Packaging date, destina-
tion/procedure, sample-order id pair 
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o If the samples need to be prepared and/or coded in a specific way 
before being sent out, the procedures/coding should be docu-
mented 
 The workbench is thoroughly cleaned after each sample batch 
 The workbench and surrounding area should be scheduled to be thor-
oughly decontaminated periodically 
 
Post-analytic phase and test results 
 The test results are documented to the laboratory notebook 
o The notes should include: numerical values, procedure, date, au-
thor 
 Test reports and notes should include patient/sample id 
o Samples that have been sent out for analysis should be marked 
in a way that prevents mix-up when the results come back 
 In case the method chosen produces results that need interpretation, the 
laboratory should have documented procedures and policies how the re-
sults are interpreted 
 The results should be reported in a way that accounts for the customer’s 
education, e.g. a layman versus a physician 
 If the results are reported electronically, the transmission methods should 
be secure 
 If the results are retained, the retention time should be documented and 
pre-established 
o Back-up procedures and schedules should be established and 
documented
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Appendix 2: Primer pairs 
The primer pairs tested during the laboratory experiment were: 
Primer pairs Sequences 
GJB6-1R/BKR-1  
(5’-TTT AGG GCA TGA TTG GGG TGA TTT-3’)/(5’-
CAC CAT GCG TAG CCT TAA CCA TTT T-3’) 
DelBK1/DelBK2 
(5’-TCA TAG TGA AGA ACT CGA TGC TFT TT-
3’)/(5’-CAG CGG CTA CCC TAG TTG TGG T-3’) 
Cx30Ex1A/Cx30Ex1B 
(5’-CGT CTT TGG GGG TGT TGC TT-3’)/(5’-CAT 
GAA GAG GGC GTA CAA GTT AGA A-3’) 
Cx26-1F/Cx26-1R 
(5’-TCT TTT CCA GAG CAA ACC GC-3’)/(5’-GAC 
ACG AAG ATC AGC TGC AG-3’) 
Cx26-2F/Cx26-2R 
(5’-CCA GGC TGC AAG AAC GTC TG-3’)/(5’-GGG 
CAA TFC GTT AAA CTG GC-3’ 
 
